Skip to search formSkip to main contentSkip to account menu

Adriamycin

Known as: Adriamycine, adriablastin, Adriamycin® 
National Institutes of Health

Related topics

Related topics

6 relations
Adria brand of doxorubicinAdriblastinRubex

Broader (2)

DoxorubicinDoxorubicin Hydrochloride

Narrower (1)

Liposomal Adriamycin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2007
Highly Cited
2007
Adriamycin‐mediated nitration of manganese superoxide dismutase in the central nervous system: insight into the mechanism of chemobrain
Adriamycin (ADR), a potent anti‐tumor agent, produces reactive oxygen species (ROS) in cardiac tissue. Treatment with ADR is dose… 
Review
2006
Review
2006
Adriamycin-induced oxidative mitochondrial cardiotoxicity
The anticancer agent Adriamycin (ADR) has long been recognized to induce a dose-limiting cardiotoxicity. Numerous studies have… 
Highly Cited
2006
Highly Cited
2006
Protective effect of lycopene on adriamycin-induced cardiotoxicity and nephrotoxicity.
Highly Cited
2003
Highly Cited
2003
Self-assembled nanoparticles of hydrophobically-modified polysaccharide bearing vitamin H as a targeted anti-cancer drug delivery system.
Highly Cited
1998
Highly Cited
1998
Curcumin attenuation of acute adriamycin myocardial toxicity in rats
The protective effect of curcumin on acute adriamycin (ADR) myocardial toxicity was analysed in rats. ADR toxicity, induced by a… 
Highly Cited
1990
Highly Cited
1990
Characterization and anticancer activity of the micelle-forming polymeric anticancer drug adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer.
Adriamycin (ADR), an anthracycline anticancer drug, was bound to the poly(aspartic acid) chain of poly(ethylene glycol)-poly… 
Highly Cited
1986
Highly Cited
1986
Characteristics of resistance to adriamycin in human myelogenous leukemia K562 resistant to adriamycin and in isolated clones.
An adriamycin (ADM)-resistant variant (K562/ADM) of human myelogenous leukemia K562 was established. K562/ADM was stable for 2… 
Highly Cited
1979
Highly Cited
1979
Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukemia.
Significantly decreased uptake and retention of daunorubicin (DAU) and Adriamycin (ADR) have been reported in sublines of P388… 
Review
1979
Review
1979
Adriamycin cardiotoxicity: a survey of 1273 patients.
Valuable information was collected on the medical history and clinical course of 1273 patients entered in clinical trials with… 
Highly Cited
1974
Highly Cited
1974
Electrolyte and morphologic alterations of myocardium in adriamycin-treated rabbits.
Rabbits receiving adriamycin (ADR) on a chronic schedule developed significant histopathologic, ultrastructural and tissue… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)